Nanoparticle-based Therapy for the Targeted Treatment of Metastatic Breast Cancer
University of Central Florida, Florida, United States
This nanotechnology is being developed for the treatment of metastatic breast cancer. The nanoparticle-peptide complex is designed to specifically target breast cancer cells, disrupt their ability to migrate, and induce cell death. Delivery of the complex in vivo resulted in significant tumor regression in a breast cancer mouse model.
Primary Application Area: Biotech & Biological Sciences
Technology Development Status: Prototype
Technology Readiness Level: TRL 3
FIGURES OF MERIT
Value Proposition: UCF’s technology overcomes many of the challenges associated with current breast cancer treatments. It features a cost effective nanotechnology-based platform for concentrated, targeted delivery of a proprietary therapeutic peptide. The peptide is easy to synthesize and targets a metastatic cancer phenotype, minimizing non-specific effects on healthy cells.
Organization Type: Academic/Gov Lab
Showcase Booth #: 724
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date: NIH/NIGMS 02/01/2008 - 01/31/2013
Primary Sources of Funding: Federal Grant
Looking for: Both Funding and Development Partners